SEC Form 4 · accession 0001437749-18-012804
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip J Vitale
Director
Period of report
Jun 26, 2018
Accepted (ET)
Jul 2, 2018 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.45 | Jun 26, 2018 | A | 5,000 | A | — | Jun 26, 2028 | Common Stock | 5,000 | 60,000 | D |
Explanation of responses
- F125% vested as of 6/26/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/26/2019, until fully vested.